Mikkel BAndak
0000-0003-3475-9675
9 papers found
Refreshing results…
Prognostic Factors for Relapse in Patients With Clinical Stage I Testicular Seminoma: A Nationwide, Population-Based Cohort Study
Effect of 12-months testosterone replacement therapy on bone mineral density and markers of bone turnover in testicular cancer survivors – results from a randomized double-blind trial
Smoking as a prognostic factor for survival in patients with disseminated germ cell cancer
Testicular cancer survivors have shorter anogenital distance that is not increased by 1 year of testosterone replacement therapy
Paternity After Treatment for Testicular Germ Cell Cancer: A Danish Nationwide Population-Based Cohort Study
Sexual Function and Quality of Life in a National Cohort of Survivors of Bilateral Testicular Cancer
Leydig cell dysfunction, systemic inflammation and metabolic syndrome in long-term testicular cancer survivors
A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention)
Reproductive hormones and metabolic syndrome in 24 testicular cancer survivors and their biological brothers
Missing publications? Search for publications with a matching author name.